These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34541178)

  • 1. Teratoma Formation Assay for Assessing Pluripotency and Tumorigenicity of Pluripotent Stem Cells.
    Miyawaki S; Okada Y; Okano H; Miura K
    Bio Protoc; 2017 Aug; 7(16):e2518. PubMed ID: 34541178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratoma formation: a tool for monitoring pluripotency in stem cell research.
    Nelakanti RV; Kooreman NG; Wu JC
    Curr Protoc Stem Cell Biol; 2015 Feb; 32():4A.8.1-4A.8.17. PubMed ID: 25640819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats.
    Miyawaki S; Kawamura Y; Oiwa Y; Shimizu A; Hachiya T; Bono H; Koya I; Okada Y; Kimura T; Tsuchiya Y; Suzuki S; Onishi N; Kuzumaki N; Matsuzaki Y; Narita M; Ikeda E; Okanoya K; Seino K; Saya H; Okano H; Miura K
    Nat Commun; 2016 May; 7():11471. PubMed ID: 27161380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
    An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
    Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice.
    Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu S; Hanazono Y
    Cell Transplant; 2008; 17(9):1095-102. PubMed ID: 19177845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the Incidence of Teratomas after the Transplantation of Nonhuman Primate ES Cells into Immunodeficient Mice.
    Kishi Y; Tanaka Y; Shibata H; Nakamura S; Takeuchi K; Masuda S; Ikeda T; Muramatsu SI; Hanazono Y
    Cell Transplant; 2008 Sep; 17(9):1095-1102. PubMed ID: 28863750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenicity of pluripotent stem cells: biological insights from molecular imaging.
    Kooreman NG; Wu JC
    J R Soc Interface; 2010 Dec; 7 Suppl 6(Suppl 6):S753-63. PubMed ID: 20880852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
    Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
    J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas.
    Damjanov I; Andrews PW
    Int J Dev Biol; 2016; 60(10-11-12):337-419. PubMed ID: 28000905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratoma generation in the testis capsule.
    Peterson SE; Tran HT; Garitaonandia I; Han S; Nickey KS; Leonardo T; Laurent LC; Loring JF
    J Vis Exp; 2011 Nov; (57):e3177. PubMed ID: 22158256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The teratoma assay: an in vivo assessment of pluripotency.
    Wesselschmidt RL
    Methods Mol Biol; 2011; 767():231-41. PubMed ID: 21822879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Simplified In Vitro Teratoma Assay for Pluripotent Stem Cells Injected Into Rodent Fetal Organs.
    Masuda S; Yokoo T; Sugimoto N; Doi M; Fujishiro SH; Takeuchi K; Kobayashi E; Hanazono Y
    Cell Med; 2012 Jan; 3(1-3):103-112. PubMed ID: 28058187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
    Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
    Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis.
    Lee J; Kim Y; Yi H; Diecke S; Kim J; Jung H; Rim YA; Jung SM; Kim M; Kim YG; Park SH; Kim HY; Ju JH
    Arthritis Res Ther; 2014 Feb; 16(1):R41. PubMed ID: 24490617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency.
    Gertow K; Przyborski S; Loring JF; Auerbach JM; Epifano O; Otonkoski T; Damjanov I; Ahrlund-Richter L
    Curr Protoc Stem Cell Biol; 2007 Oct; Chapter 1():Unit1B.4. PubMed ID: 18785162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
    Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
    Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review.
    Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.
    Hentze H; Soong PL; Wang ST; Phillips BW; Putti TC; Dunn NR
    Stem Cell Res; 2009 May; 2(3):198-210. PubMed ID: 19393593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratoma formation in immunocompetent mice after syngeneic and allogeneic implantation of germline capable mouse embryonic stem cells.
    Aldahmash A; Atteya M; Elsafadi M; Al-Nbaheen M; Al-Mubarak HA; Vishnubalaji R; Al-Roalle A; Al-Harbi S; Manikandan M; Matthaei KI; Mahmood A
    Asian Pac J Cancer Prev; 2013; 14(10):5705-11. PubMed ID: 24289566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.